Temblor, Brenda C.
HRN: 26-84-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2025
LEVOFLOXACIN 500MG (TAB)
04/19/2025
04/25/2025
PO
500 Mg
Od
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes